Department of Physiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pharmacol Biochem Behav. 2012 Oct;102(4):520-5. doi: 10.1016/j.pbb.2012.07.001. Epub 2012 Jul 10.
It is confirmed that pharmacological attenuation of glial cells can alleviate neuropathic pain by lowering proinflammatory cytokine expression. The present study tries to confirm that post-injury administration of glia inhibitor, minocycline, can attenuate the neuropathic pain symptoms and improves the efficacy of morphine anti-nociception in chronic constriction injury (CCI). Male Wistar rats (230-270 g) underwent surgery for induction CCI model of neuropathy. For assessment of the thermal hyperalgesia and mechanical allodynia after CCI induction, morphine (2.5, 5, 7.5, 10 and 15 mg/kg; s.c.) and saline were administered on post-operative days (PODs) 0, 6 and 14. Hargreaves and Von-Frey tests were performed before and 30 min after morphine administration, respectively. The results showed significant decrease in antinociceptive effect of morphine on POD 6 compared to POD 0 only at the dose of 5 mg/kg. On the other hand, on POD 14 the antinociceptive effect of morphine (5, 7.5, 10 and 15 mg/kg) significantly decreased in comparison with POD 0. In another set of experiments, animals received minocycline (10, 20 and 40 mg/kg; i.p.) for eight days from POD 6 to 13 and then the antinociceptive effect of single dose of morphine 5 mg/kg was tested on POD 14. Behavioral tests showed that minocycline (40 mg/kg) could effectively attenuate the thermal hyperalgesia and mechanical allodynia on POD 13. Moreover, minocycline (40, 20 mg/kg) improved the anti-hyperalgesic, and minocycline (40 mg/kg) improved the anti-allodynic effects of morphine 5 mg/kg on POD 14. It seems that the reduction of antinociceptive effect of morphine after CCI may be mediated through glia activation. Modulation of glial activity by minocycline can attenuate CCI-induced neuropathic pain. It is also shown that repeated post-injury administration of minocycline improves the antinociceptive effect of morphine in neuropathic pain.
研究证实,通过降低促炎细胞因子的表达,抑制神经胶质细胞可减轻神经病理性疼痛。本研究旨在证实,损伤后给予神经胶质抑制剂米诺环素,可减轻神经病理性疼痛症状,并提高慢性缩窄性损伤(CCI)中吗啡的抗伤害作用。雄性 Wistar 大鼠(230-270g)行手术诱导神经病变 CCI 模型。CCI 诱导后,评估热痛觉过敏和机械性痛觉过敏,术后第 0、6 和 14 天给予吗啡(2.5、5、7.5、10 和 15mg/kg;sc)和生理盐水。在给予吗啡前和 30 分钟后分别进行 Hargreaves 和 Von-Frey 试验。结果显示,与术后第 0 天相比,术后第 6 天,只有 5mg/kg 吗啡的镇痛作用显著降低。另一方面,术后第 14 天,与术后第 0 天相比,吗啡(5、7.5、10 和 15mg/kg)的镇痛作用明显降低。在另一组实验中,从术后第 6 天到第 13 天,动物连续 8 天给予米诺环素(10、20 和 40mg/kg;ip),然后在术后第 14 天测试单剂量 5mg/kg 吗啡的镇痛作用。行为学测试显示,米诺环素(40mg/kg)可有效减轻术后第 13 天的热痛觉过敏和机械性痛觉过敏。此外,米诺环素(40、20mg/kg)可增强吗啡 5mg/kg 的抗痛觉过敏作用,米诺环素(40mg/kg)可增强吗啡 5mg/kg 的抗痛觉过敏作用。CCI 后吗啡镇痛作用的降低可能是通过胶质细胞激活介导的。米诺环素对胶质细胞活性的调节可减轻 CCI 诱导的神经病理性疼痛。此外,反复给予损伤后米诺环素可提高神经病理性疼痛中吗啡的镇痛作用。